Several neonatal disorders can benefit from ERT, including Pompe Disease, Fabry Disease, and Mucopolysaccharidoses (MPS). These are all lysosomal storage disorders caused by the deficiency of specific enzymes. The absence of these enzymes leads to the accumulation of toxic substances in the cells, causing a range of symptoms.
